Keeping Track: Novel Approvals For Diacomit, Takhzyro And Oxervate; CRLs For Mallinckrodt And Allergan

 
• By Michael Cipriano

The latest drug development news and highlights from our US FDA Performance Tracker.

More from Product Reviews

More from Pink Sheet